JDRF T1D FUND
The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities to accelerate the delivery of treatments, preventions, and cures to patients. It was created to solve a critical funding gap in the T1D drug and device development pipeline. Through partnerships with private capital, including venture capital, pharma and foundations, the T1D Fund anticipates that it will be able to attract substantially m... ore private investment to the T1D field than occurs today. The T1D Fund will initially focus on artificial pancreas systems, metabolic control, beta cell replacement, prevention, and beta cell restoration therapies, with an exclusive priority on the best commercial opportunities. The T1D Fund will reinvest any realized gains into new investments to further its mission.
JDRF T1D FUND
Founded:
2016-12-01
Status:
Active
Contact:
212-689-2860
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Intrinsic Capital Partners
A private equity fund dedicated to investing in promising growth businesses in the emerging legal cannabis industry.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-07 | Code Biotherapeutics | JDRF T1D Fund investment in Series A - Code Biotherapeutics | 75 M USD |
| 2022-05-16 | Kriya Therapeutics | JDRF T1D Fund investment in Series C - Kriya Therapeutics | 270 M USD |
| 2022-03-29 | Jaguar Gene Therapy | JDRF T1D Fund investment in Venture Round - Jaguar Gene Therapy | N/A |
| 2021-11-02 | Biolinq | JDRF T1D Fund investment in Series B - Biolinq | 100 M USD |
| 2021-08-11 | GentiBio | JDRF T1D Fund investment in Series A - GentiBio | 157 M USD |
| 2021-08-04 | Sonoma BioTherapeutics | JDRF T1D Fund investment in Series B - Sonoma BioTherapeutics | 265 M USD |
| 2021-07-14 | Kriya Therapeutics | JDRF T1D Fund investment in Series B - Kriya Therapeutics | 100 M USD |
| 2021-06-23 | Abata Therapeutics | JDRF T1D Fund investment in Series A - Abata Therapeutics | 95 M USD |
| 2021-06-16 | Veralox Therapeutics | JDRF T1D Fund investment in Series A - Veralox Therapeutics | 16.6 M USD |
| 2021-04-20 | Code Biotherapeutics | JDRF T1D Fund investment in Seed Round - Code Biotherapeutics | 10 M USD |
More informations about "JDRF T1D Fund"
JDRF is now Breakthrough T1D
Jun 4, 2024 Breakthrough T1D has led the search for cures for T1D since the organization got its start more than 50 years ago. The non-profit was founded in 1970 by families of children living with T1D when the disease was known as …See details»
Breakthrough T1D
We are now Breakthrough T1D™ – the organization formerly known as JDRF Canada rebrands to recognize impact of type 1 diabetes on Canadians of all ages ... October 11, 2024. A joint …See details»
We are now Breakthrough T1D™ – the organization formerly …
Oct 31, 2024 The leading type 1 diabetes (T1D) research and advocacy organization unveils its new identity to better reflect the community it serves while working to accelerate …See details»
Breakthrough T1D - Wikipedia
Breakthrough T1D supports two main research objectives: • Cure T1D by restoring the body’s ability to make insulin and stopping T1D before it occurs or providing insulin independence through replacement with insulin-producing cells. • Improve lives by minimizing the effects of T1D as much as possible until ne…See details»
About the T1D Fund: A Breakthrough T1D Venture
The Relationship Between Breakthrough T1D (Formerly JDRF) & The T1D Fund ... By investing in areas strategically aligned with Breakthrough T1D (formerly JDRF), the leading global T1D …See details»
Our Approach To Investing - T1D Fund: A Breakthrough T1D Venture
All investments are reviewed on a rolling basis where the T1D Fund team will assess if the opportunity aligns with the T1D Fund’s overall investment strategy and mission. Diligence Our …See details»
Type 1 Diabetes - Breakthrough T1D
Breakthrough T1D is the leading global type 1 diabetes (T1D) research and advocacy organization. As we drive toward curing type 1 diabetes, we help make everyday life better for the people who face it.See details»
Type 1 Diabetes Support, Research, and Advocacy
Founded in 1970 by families whose loved ones had been diagnosed with type 1 diabetes (T1D), Breakthrough T1D is a tax-exempt nonprofit 501(c)3 organization. As the leading global type 1 diabetes research and advocacy organization, we …See details»
JDRF Is Now 'Breakthrough T1D' - The JDCA
Jun 4, 2024 The organization says this move was made “to align our brand with who we are today.” The name and brand change comes after two years of research and insight collection from the T1D community. The organization …See details»
JDRF is Now Breakthrough T1D - PR Newswire
Jun 4, 2024 NEW YORK and WASHINGTON, June 4, 2024 /PRNewswire/ -- Today, JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, announced that it is now Breakthrough T1D.See details»
Our Portfolio - T1D Fund: A Breakthrough T1D Venture
The T1D Fund is a venture philanthropy fund accelerating life-changing solutions to treat, prevent, and ultimately cure T1D. ... By investing in areas strategically aligned with Breakthrough T1D …See details»
Charity Navigator - Rating for Breakthrough T1D
This Charitable Organization is headquartered in New York, NY. Breakthrough T1D has earned a 4/4 Star rating on Charity Navigator. This Charitable Organization is headquartered in New …See details»
Investing in Type 1 Innovation—JDRF’s T1D Fund - Beyond Type 1
Sep 16, 2024 How the T1D Fund Works. To get the T1D Fund started, JDRF provided $32 million of investment capital over four years. The T1D Fund is also funded by private donors, …See details»
JDRF T1D Fund - Crunchbase Investor Profile & Investments
The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities to accelerate the …See details»
News and Press - JDRF T1D Fund
San Francisco – January 26, 2017 . JDRF, the leading global organization funding type 1 diabetes (T1D) research, today announced the launch of the JDRF T1D Fund, a new venture …See details»
Breakthrough T1D 2023: How Money Was Earned and Used - The …
Jun 18, 2024 A sizable portion of short-term investments (approximately $100 million) are held by the T1D Fund, and the remaining $88 million is held by the Breakthrough T1D parent …See details»
Jaguar Gene Therapy Announces Samsung and JDRF T1D Fund as …
Mar 29, 2022 The T1D Fund invests in areas strategically aligned with JDRF, the leading global organization funding T1D research, with an exclusive focus on supporting the best commercial …See details»
Funding Opportunities - Breakthrough T1D
Grant handbook A comprehensive collection of Breakthrough T1D’s grant mechanisms and descriptions; application guidelines and checklists; administrative resources; terms and …See details»
JDRF 2021: How Money was Earned and Used - The JDCA
Jul 14, 2022 Total organization revenue, which combines both JDRF and the JDRF T1D Fund, reached $242 million in 2021, the highest level since 2001. However, much of this record …See details»